Healthcare provider profile · identity verified

Daniel Eggleston, DO

Family Practice · WEST READING, PA · NPI 1376035535

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	310	82
Levothyroxine Sodium	Levothyroxine Sodium	218	58
Lisinopril	Lisinopril	202	59
Amlodipine Besylate	Amlodipine Besylate	186	52
Gabapentin	Gabapentin	141	31
Losartan Potassium	Losartan Potassium	136	40
Hydrochlorothiazide	Hydrochlorothiazide	109	35
Omeprazole	Omeprazole	100	31
Simvastatin	Simvastatin	98	27
Metformin Hcl	Metformin Hcl	95	26
Pantoprazole Sodium	Pantoprazole Sodium	94	21
Rosuvastatin Calcium	Rosuvastatin Calcium	92	30
Furosemide	Furosemide	86	19
Sertraline Hcl	Sertraline Hcl	84	26
Lorazepam	Lorazepam	73	23
Eliquis	Apixaban	71	13
Potassium Chloride	Potassium Chloride	64	suppressed
Metoprolol Succinate	Metoprolol Succinate	60	19
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Meloxicam	Meloxicam	57	39
Zolpidem Tartrate	Zolpidem Tartrate	56	16
Trazodone Hcl	Trazodone Hcl	55	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	18
Montelukast Sodium	Montelukast Sodium	54	14
Famotidine	Famotidine	52	13
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	50	14
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	20
Pravastatin Sodium	Pravastatin Sodium	48	18
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Atenolol	Atenolol	46	suppressed
Prednisone	Prednisone	45	40
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	37
Buspirone Hcl	Buspirone Hcl	42	12
Carvedilol	Carvedilol	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	14
Tamsulosin Hcl	Tamsulosin Hcl	41	14
Albuterol Sulfate Hfa	Albuterol Sulfate	40	26
Warfarin Sodium	Warfarin Sodium	39	suppressed
Ozempic	Semaglutide	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Jardiance	Empagliflozin	35	suppressed
Spironolactone	Spironolactone	35	13
Alendronate Sodium	Alendronate Sodium	34	suppressed
Baclofen	Baclofen	34	suppressed
Lactulose	Lactulose	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	29
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	19
Glipizide	Glipizide	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Digoxin	Digoxin	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Alprazolam	Alprazolam	26	12
Cephalexin	Cephalexin	26	22
Donepezil Hcl	Donepezil Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Azithromycin	Azithromycin	21	21
Doxycycline Hyclate	Doxycycline Hyclate	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Estradiol	Estradiol	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	12
Metformin Hcl Er	Metformin Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Belsomra	Suvorexant	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Risperidone	Risperidone	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Nystatin	Nystatin	14	12
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Valsartan	Valsartan	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Dexamethasone	Dexamethasone	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Azathioprine	Azathioprine	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Diazepam	Diazepam	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error